Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 04 Jun 2026 for Janux Therapeutics, Inc., €49k. Read the official filing
Filing timeline
BuySaleJaneen Noel Doyle
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Janeen Noel Doyle: trading record in brief
Janeen Noel Doyle appears in our data through filings on Janux Therapeutics, Inc. shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 2 June 2025 and the latest from 2 June 2026.
The open-market record consists of 1 sale worth €49k, with no purchase. Other entries cover 2 share grants. Since January 2026: no purchases and 1 sale on the market.
The newest entry dates from 4 June 2026: an open-market sale of €49k, in Janux Therapeutics, Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Janeen Noel Doyle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
4,059 shares@ US$14.0290.0059% mcap100.0% of flowCommon StockSEC:0002069239-26-000005:0
36,000 shares0Common StockSEC:0002069239-26-000002:0
44,000 shares0Common StockSEC:0001415889-25-015684:0
3 of 3 declarations
